Landmark trials show semaglutide (Wegovy) produces 10-15% body weight reduction over 68 weeks, while tirzepatide achieves 20-22% reduction by targeting dual GLP-1 and GIP pathways
Holistic Health Improvements Tirzepatide treatment not only helps with weight but also dramatically enhances metabolic health by improving blood sugar control, blood pressure levels, and cholesterol profiles
Nephrologists defined their ideal patient as someone with diabetic kidney disease exhibiting persistently elevated urinary albumin-to-creatinine ratio (ACR) or decline in eGFR with proper reninangiotensinaldosterone system (RAAS) blockade, starting with SGLT2is first and subsequently adding GLP1-RAs
Safety is a common concern with any IV treatment, and its wise to ask, Is glutathione IV safe for me? Generally speaking, glutathione IV therapy is considered safe for most healthy adults when administered by qualified medical professionals
Adequate antioxidant levels may help mitigate these risks
Egert, S., Boesch-Saadatmandi, C., Wolffram, S., Rimbach, G